Cas No.: | 64748-79-4 |
Chemical Name: | Azumolene |
Synonyms: | 2,4-Imidazolidinedione,1-[[[5-(4-bromophenyl)-2-oxazolyl]methylene]amino]-;1-[[5-(4-bromophenyl)-1,3-oxazol-2-yl]methylideneamino]imidazolidine-2,4-dione;1-(((5-(4-bromophenyl)-2-oxazolyl)methylene)amino)-2,4-imidazolidinedione;1-[5-(4-bromo-phenyl)-oxazol-2-ylmethyleneamino]-imidazolidine-2,4-dione;Azumolene;Azumolene [INN];Azumoleno;Azumoleno [Spanish];Azumolenum;Azumolenum [Latin];UNII-5U7IO9CV80 |
SMILES: | BrC1=CC=C(C2=CN=C(/C=N/N3CC(=O)NC3=O)O2)C=C1 |
Formula: | C13H9BrN4O3 |
M.Wt: | 349.14000 |
Purity: | >98% |
Sotrage: | Please store the product under the recommended conditions in the Certificate of Analysis. |
Description: | Azumolene (EU4093 free base), a Dantrolene analog, is a muscle relaxant. Azumolene is a ryanodine receptor (RyR) modulator and inhibits the calcium-release through ryanodine receptor. Azumolene can be used for malignant hyperthermia research[1][2]. |
In Vivo: | The effect of Azumolene (EU4093) on the twitch of the intact rat soleus preparation is nearly maximal at a dose of 20 mg/kg. This dose of Azumolene reduces the amplitude of the twitch to 31.9% of the control value. The contraction of intrafusal muscle as measured by the response of spindle afferent discharge is also reduced by Azumolene[1]. |
In Vitro: | Pretreatment with 20 µM Azumolene for 1-2 min inhibits SOCE activated by subsequent addition of caffeine and ryanodine to promote RyR-dependent sarcoplasmic reticulum Ca2+ store depletion in mouse myotubes and adult muscle fibers[2]. |
References: | [1]. G C Leslie, et al. The effect of EU4093 (azumolene sodium) on the contraction of intrafusal muscle in the soleus muscle of the anaesthetized rat. Br J Pharmacol. 1989 Aug;97(4):1151-6. [2]. Viktor Yarotskyy, et al. Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death. PLoS One. 2013 Oct 15;8(10):e77633. |